Exploring the Role of a Novel HPV16-Targeted Cancer T-cell Stimulating Immunotherapy (TSI) (Versamune® HPV) for Human Papilloma Virus (HPV) Positive Head and Neck Cancer (HNSCC) - Episode 1

Introduction and Incidence of HPV-Positive Head and Neck Cancer

A panelist discusses the incidence of HPV+ HNSCC, and how has it changed in recent years.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Video content above is prompted by the following:

    Current Incidence of HPV+ HNSCC 

    • Please discuss the current incidence of HPV+ HNSCC, and how has it changed in recent years?
    • Please address specific populations or demographics most affected
    • What are the main differences between HPV+ and HPV- HNSCCs in terms of biology and patient outcomes?
    x